John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$272M |
| 2 |
PayPal
PYPL
|
+$237M |
| 3 |
Tesla
TSLA
|
+$223M |
| 4 |
Advanced Micro Devices
AMD
|
+$169M |
| 5 |
Cencora
COR
|
+$165M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$293M |
| 2 |
JPMorgan Chase
JPM
|
+$226M |
| 3 |
GSK
GSK
|
+$219M |
| 4 |
Procter & Gamble
PG
|
+$202M |
| 5 |
Accenture
ACN
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.55% |
| 2 | Healthcare | 16.09% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.25% |
| 5 | Consumer Discretionary | 10.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1576
V2X
VVX
$2.43B
| $1.22M | ﹤0.01% |
29,480
-11,076
| -27% | -$439K |
|
1577
Summit Therapeutics
SMMT
$10.2B
| $1.22M | ﹤0.01% |
+286,200
| New | +$521K |
|
|
PLTNU
1578
DELISTED
Plutonian Acquisition Corp. Unit
PLTNU
| $1.21M | ﹤0.01% |
+120,329
| New | +$1.21M |
|
1579
Ashland
ASH
$3.38B
| $1.21M | ﹤0.01% |
+11,253
| New | +$1.19M |
|
1580
Bain Capital Specialty
BCSF
$786M
| $1.21M | ﹤0.01% |
101,623
-40,276
| -28% | -$512K |
|
|
SLGC
1581
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.21M | ﹤0.01% |
481,355
-105,249
| -18% | -$294K |
|
1582
PagSeguro Digital
PAGS
$2.4B
| $1.21M | ﹤0.01% |
+138,054
| New | +$1.62M |
|
1583
Lufax Holding
LU
$1.17B
| $1.21M | ﹤0.01% |
+155,375
| New | +$1.18M |
|
1584
Forestar Group
FOR
$1.47B
| $1.2M | ﹤0.01% |
78,180
+27,285
| +54% | +$361K |
|
1585
OneSpan
OSPN
$575M
| $1.2M | ﹤0.01% |
107,657
+12,862
| +14% | +$148K |
|
1586
Twist Bioscience
TWST
$8.83B
| $1.2M | ﹤0.01% |
50,500
-34,501
| -41% | -$1M |
|
1587
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.92B
| $1.2M | ﹤0.01% |
7,800
+5,100
| +189% | +$752K |
|
1588
Puma Biotechnology
PBYI
$471M
| $1.2M | ﹤0.01% |
283,950
+200,343
| +240% | +$691K |
|
1589
TriNet
TNET
$3.19B
| $1.2M | ﹤0.01% |
17,700
-61,643
| -78% | -$4.25M |
|
1590
J. Jill
JILL
$299M
| $1.2M | ﹤0.01% |
+48,358
| New | +$1.07M |
|
1591
AptarGroup
ATR
$8.57B
| $1.19M | ﹤0.01% |
+10,861
| New | +$1.12M |
|
1592
Lakeland Financial Corp
LKFN
$1.5B
| $1.19M | ﹤0.01% |
16,357
+1,644
| +11% | +$126K |
|
1593
American Public Education
APEI
$846M
| $1.19M | ﹤0.01% |
97,086
-20,796
| -18% | -$258K |
|
|
CMPS
1594
Compass Pathways
CMPS
$1.97B
| $1.19M | ﹤0.01% |
148,520
-43,287
| -23% | -$434K |
|
1595
Paysafe
PSFE
$347M
| $1.19M | ﹤0.01% |
85,377
-105,293
| -55% | -$1.7M |
|
|
BLU
1596
DELISTED
BELLUS Health Inc.
BLU
| $1.19M | ﹤0.01% |
144,194
+11,594
| +9% | +$108K |
|
1597
CytomX Therapeutics
CTMX
$717M
| $1.19M | ﹤0.01% |
740,724
+382,763
| +107% | +$566K |
|
1598
Wave Life Sciences
WVE
$1.01B
| $1.18M | ﹤0.01% |
168,927
+105,261
| +165% | +$485K |
|
|
CSII
1599
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.18M | ﹤0.01% |
86,732
+68,564
| +377% | +$955K |
|
1600
Williams Companies
WMB
$86.8B
| $1.18M | ﹤0.01% |
+35,800
| New | +$1.17M |
|
Similar funds
John Overdeck's Q4 2022 Portfolio in Review
As of Q4 2022, John Overdeck held 3,245 positions worth $31.9B, up 8.2% from $29.4B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
John Overdeck's Q4 2022 filing shows 801 new, 908 increased, 911 reduced and 472 closed positions. Its largest new stake was Yum! Brands: 1,187,068 shares worth $152M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $293M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 22% a quarter earlier, followed by Healthcare and Financials.
- John Overdeck's largest Q4 2022 buy was Yum! Brands: 1,187,068 shares worth $152M.
- John Overdeck added most to Amazon in Q4 2022, an estimated $272M increase.
- John Overdeck's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $293M.
- John Overdeck fully exited JPMorgan Chase in Q4 2022, selling an estimated $226M.
- John Overdeck's ten largest holdings make up 7.9% of its $31.9B portfolio in Q4 2022.
- John Overdeck opened 801 new positions and closed 472 in Q4 2022.
- John Overdeck's portfolio value rose 8.2% quarter-over-quarter to $31.9B.
Based on Two Sigma Investments's 13F filing for Q4 2022, filed 14 Feb 2023.